About this trial
: Patient readmission to PICU is a major point of concern for physicians because, although being a rare event, it has been strongly associated with more morbidity and death. Patient monitoring once they have left the PICU is drastically modified, and small connected devices could be an option to early identify patients at risk of PICU readmission. Such devices have been manufactured for the recording of vital signs in adults, but they do not exist for children.
Besides, studies have recently shown that devices that use optical sensors may be less accurate in individuals with dark skin pigmentation since dark skin tones impose a limitation on optical biometric sensing. The wearable and medical device industry has not sufficiently addressed this issue yet. This is one of the main challenges that need to be addressed in this area to make sure the connected devices using this technology will work with all different skin colours including very dark skin.
Eligibility criteria
Qualifiers
PICU monitoring for the next 24 hours
Disqualifiers
Recent cardiac or thoracic surgery
Thoracic skin lesion that contraindicates the VT patch
No parental consent
Intermittent presence of one study observer in the patient room considered inappropriate by the physician or the nurse in charge because of the child's medical condition
Trial design
Treatments tested in this trial
- Non-invasive monitoring
Treatment groups
Sponsors and collaborators
VitalTracer Ltd.
Lead sponsor
St. Justine's Hospital
Collaborator